Hydro One to Release Fourth Quarter 2025 Results on February 13, 2026 Before Markets Open

Investment Community Teleconference Set for February 13, 2026 at 8 a.m. ET Hydro One Limited (TSX: H), the largest electric transmission and distribution utility in Ontario, plans to release its fourth quarter financial results the morning of February 13, 2026, before North American financial markets open. A summary of the results will be distributed by

Hormel Foods Announces Upcoming Retirements of Mark Morey and Paul Peil

Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, today announced the upcoming retirements of two long-tenured leaders: Mark Morey, vice president of operations for fresh pork, and Paul Peil, vice president of marketing for fresh and ready meats. “Mark has been a trusted leader at Hormel Foods for more than three

Streetline Expands AI-Powered Smart Truck Parking Availability System to I-5 Corridor in the State of Washington

Streetline Expands AI-Powered Smart Truck Parking Availability System to I-5 Corridor in the State of Washington Expanded multi-site, multi-corridor deployment enhances freight mobility for west coast ports and trucking corridors from California I-10 to Washington I-5 GlobeNewswire January 12, 2026 SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Streetline, a leader in intelligent transportation systems,

Bitdeer Announces December 2025 Production and Operations Update

Bitdeer Announces December 2025 Production and Operations Update GlobeNewswire January 12, 2026 Increased self-mining hashrate to 55.2 EH/s on continued deployment of SEALMINERs Bitcoin production increased 339% year over year to 636 Bitcoin 8 units of GB200 deployed and under testing in Malaysia SINGAPORE, Jan. 12, 2026 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (NASDAQ: BTDR)

Ingersoll Rand Schedules Fourth Quarter 2025 Earnings Release and Conference Call

Ingersoll Rand Schedules Fourth Quarter 2025 Earnings Release and Conference Call GlobeNewswire January 12, 2026 DAVIDSON, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) — Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, will issue its fourth quarter 2025 earnings release after the market closes on Thursday,

Canoe Financial announces the final amount of the special non-cash distribution for Canoe EIT Income Fund

Canoe Financial announces the final amount of the special non-cash distribution for Canoe EIT Income Fund GlobeNewswire January 12, 2026 CALGARY, Alberta, Jan. 12, 2026 (GLOBE NEWSWIRE) — Canoe Financial LP (the “Manager”) today announced the final amount of the special non-cash distribution for Canoe EIT Income Fund (the “Fund”) (TSX: EIT.UN). Unitholders of record

MKS Inc. Unveils Photonics Solutions to Advance AI, Quantum, and Biotech at Photonics West 2026

MKS Inc. Unveils Photonics Solutions to Advance AI, Quantum, and Biotech at Photonics West 2026 Driving Innovation Across Emerging Markets and Transformative Technologies GlobeNewswire January 12, 2026 ANDOVER, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) — MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, will showcase its latest advances at

CareMed Has Been Selected as a National Specialty Pharmacy Provider for MYQORZO(TM) (aficamten)

CareMed Has Been Selected as a National Specialty Pharmacy Provider for MYQORZO(TM) (aficamten) GlobeNewswire January 12, 2026 NEW HYDE PARK, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) — CareMed(R), an independent specialty pharmacy, has been selected as a pharmacy partner by Cytokinetics for MYQORZO(TM) (aficamten), indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy

Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer

Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer GlobeNewswire January 12, 2026 WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Lisa

Scroll to Top